Larvol Delta - Phase-II-Study-of-Crenolanib-in-Subjects-With-RelapsedRefractory-AML-With-FLT3-Activating-Mutations

crenolanib (ARO-002) - AROG

http://clinicaltrials.gov/ct2/show/NCT01522469

Feb 16, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next